Investor Presentaiton

For personal use only Illuccix® is now approved in the United States Indication and usage information Illuccix is a kit for the preparation of gallium-68 (68Ga) gozetotide (also known as PSMA-11) injection, a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in patients with prostate cancer with: • Suspected metastasis who are candidates for initial definitive therapy; Suspected recurrence based on elevated serum prostate- specific antigen (PSA) level. Important Safety Information: https://www.illuccixhcp.com/important-safety-information Please see full Prescribing Information at http://illuccixhcp.com/s/illuccix-prescribinginformation.pdf illuccix® (kit for the preparation of gallium Ga 68 gozetotide Injection) Telix Pharmaceuticals Limited (ASX: TLX) PSMA-11 Sterile Vial Content: 25 ug of PSMA-11 or (+2°C to +8°C) protec Not for direct human use Product Ref: Lot: Expiry date: SV.GA MOCK-UP NIA Sterile Vacuumed endor (+2°C to +8°C pro Product Ref: Lots Expiry date: Vial SVAY MOCK-UP NA rile Acetate Content: 64 mL of Acetate Buffer Buffer Val with gum-68 in 1.1 ml of a/M gror (+2°C to 8°C Not for direct human e Product Ref: Lot: Expiry date SUBRACE MOCK-UP NA TELIX PHARMACEUTICALS 22 22

View entire presentation